Apollon Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Apollon Wealth Management's FBT Position: Q2 2026 in Review
Apollon Wealth Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.6% in Q2 2026, selling an estimated $68.7K and leaving 3,865 shares worth $958K. The position accounts for 0.01% of the portfolio, ranked #752.
Apollon Wealth Management first reported a position in FBT in Q4 2021 and has held it in 19 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Apollon Wealth Management held 3,865 shares of First Trust NYSE Arca Biotechnology Index Fund worth $958K as of Q2 2026.
- Apollon Wealth Management sold 319 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $68.7K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #752 holding.
- Apollon Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2021 and has held it in 19 quarters since.
- 340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.